Insurance; medically necessary expenses for standard fertility preservation services when a medically necessary treatment for cancer, sickle cell disease, or lupus may directly or indirectly cause iatrogenic infertility; require coverage
If enacted, the bill will ensure that every health benefit policy issued or renewed after July 1, 2025, will include coverage for standard fertility preservation services when patients are at risk of infertility due to their medically necessary treatments. Coverage will encompass evaluation expenses, laboratory assessments, and storage of gametes for up to one year. However, it also allows for certain exclusions, including limitations on storage duration and age restrictions.
House Bill 1204 aims to amend the Official Code of Georgia Annotated to mandate insurance coverage for medically necessary standard fertility preservation services. This requirement is specifically targeted at individuals undergoing medically necessary treatments for cancer, sickle cell disease, or lupus, which have the potential to cause iatrogenic infertility. The bill defines key terms such as 'health benefit policy', 'iatrogenic infertility', and 'standard fertility preservation services', thus laying the groundwork for ensuring that affected individuals can access necessary fertility preservation measures.
The discussions surrounding HB 1204 may touch on potential points of contention, particularly regarding the associated costs and implications for insurers. Critics may raise concerns about the financial burden on insurance providers and the potential for increased premiums. Additionally, there could be debates over the limitations outlined for coverage, including age restrictions and the exclusion of costs for storage beyond one year. Proponents, however, argue that such coverage is critical for individuals facing life-altering medical treatments, thereby reinforcing their right to preserve their fertility.